Table 5.
Disease severity according to age. CPAP, continuous positive airway pressure; HFNC, high-flow nasal cannulae; PICU, pediatric intensive care unit.
| 216 Patients with an Identified Virus | 12 Months or Less n = 193 |
>12 Months n = 23 |
p-Value |
|---|---|---|---|
| RSV, n (%) | 147 (76.17) | 15 (65.22) | 0.25 |
| Rhinovirus, n (%) | 38 (19.69) | 10 (43.48) | 0.009 |
| SARS-CoV-2, n (%) | 18 (9.33) | 0 | 0.12 |
| Human-Metapneumovirus, n (%) | 11 (5.70) | 1(4.35) | 0.79 |
| Parainfluenza, n (%) | 9 (4.66) | 0 | 0.36 |
| Adenovirus, n (%) | 1 (0.50) | 1 (4.35) | 0.2 |
| Other viruses, n (%) | 8 (4.15) | 6 (26.09) | 0.001 |
| Coinfection, n (%) | 37 (19.17) | 6 (26.9) | 0.294 |
| 657 total patients |
12 months or less
n = 548 |
>12 months
n = 109 |
p-Value |
| Admitted to hospital, n (%) | 315 (57.48) | 53 (48.62) | 0.09 |
| Admitted to PICU, n (%) | 21 (3.83) | 5 (4.59) | 0.72 |
| Admitted to PICU within the first 7 days since initial evaluation, n (%) | 34 (6.20) | 5 (4.59) | 0.34 |
| Need for High Flow Oxygen *, n (%) | 148 (27.01) | 19 (17.43) | 0.04 |
| CPAP *, n (%) | 35 (6.39) | 8 (7.34) | 0.71 |
| Mechanical ventilation *, n (%) | 1 (0.18) | 1 (0.92) | 0.3 |
* Calculated if anytime needed within the first seven days since the initial hospital evaluation.